Who are SUCCINYLCHOLINE CHLORIDE's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): CISATRACURIUM BESYLATE, Rocuronium.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/succinylcholine-chloride.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

SUCCINYLCHOLINE CHLORIDE — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SUCCINYLCHOLINE CHLORIDE (SUCCINYLCHOLINE CHLORIDE) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

marketed cholinergic receptors Small molecule Live · refreshed every 30 min

Target snapshot

SUCCINYLCHOLINE CHLORIDE (SUCCINYLCHOLINE CHLORIDE). Succinylcholine binds to cholinergic receptors, causing initial muscle fasciculations followed by flaccid paralysis.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
SUCCINYLCHOLINE CHLORIDE TARGET	SUCCINYLCHOLINE CHLORIDE		marketed		cholinergic receptors	1952-01-01
CISATRACURIUM BESYLATE	CISATRACURIUM BESYLATE		marketed		cholinergic receptors	1995-01-01
Rocuronium	Rocuronium Bromide	Merck & Co.	marketed	Nondepolarizing neuromuscular blocking agent	Cholinergic receptors at the motor end-plate	1994-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2039-07-22 — Rocuronium · 11998605 · Formulation · US

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SUCCINYLCHOLINE CHLORIDE — Competitive Intelligence Brief. https://druglandscape.com/ci/succinylcholine-chloride. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing